Jurkat-Clone E6-1 In Vitro Anti-Tumor Efficacy Assay

This assay is to provide Jurkat-Clone E6-1-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

Jurkat-Clone E6-1

Human

Jurkat, Clone E6-1 is a clone of the Jurkat-FHCRC cell line, a derivative of the Jurkat cell line, which was established from the peripheral blood of a 14-year-old, male, acute T-cell leukemia patient. This cell line can be used in immune system disorder research and immunology and immuno-oncology research.

Acute Lymphoblastic Leukemia; ALL

Oncology

In Vitro Anti-Tumor Efficacy Assay

Jurkat-Clone E6-1-cell based In Vitro Anti-Tumor Efficacy Assay

Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.

Oncology Efficacy Assays